Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 13/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 12/20 | 0.34 |
| ▸ | MMP1 | P03956 | 2/20 | 0.34 |
| ▸ | MMP2 | P08253 | 2/20 | 0.34 |
| ▸ | MMP9 | P14780 | 2/20 | 0.34 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
| ▸ | MMP13 | P45452 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7141002 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL810923 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL811565 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL28450248 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL159453 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL428765 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL10622506 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL810417 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL3217875 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL10617899 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118161340-B | Aqueous humor drainage tube | 明澈生物科技(苏州)有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118161340-A | Aqueous humor drainage tube | 明澈生物科技(苏州)有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-11649202-B2 | Fluorinated esters as lubricants for heat transfer fluids | MEXICHEM FLUOR S.A. DE C.V. (MX) | 2023-05-16 | — | — | US | claimed |
| CN-111499901-B | Preparation method of fluorine-containing polymer/polyimide composite film | 东莞东阳光科研发有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-111635546-B | Preparation method of fluorine-containing polymer/polyimide composite film | 东莞东阳光科研发有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-113336492-A | Durable foam concrete and preparation method thereof | 北京慕湖新材料技术有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-111635546-A | Preparation method of fluorine-containing polymer/polyimide composite film | 东莞东阳光科研发有限公司 | 2020-09-08 | — | — | CN | claimed |
| CN-111499901-A | Preparation method of fluorine-containing polymer/polyimide composite film | 东莞东阳光科研发有限公司 | 2020-08-07 | — | — | CN | claimed |
| EP-3529300-B1 | PLASTICIZED PVC ADMIXTURES WITH SURFACE MODIFYING MACROMOLECULES AND ARTICLES MADE THEREFROM | EVONIK CANADA INC (CA) | 2026-05-06 | — | — | EP | disclosed |
| EP-3630212-B1 | VASCULAR GRAFTS HAVING A MODIFIED SURFACE | EVONIK CANADA INC (CA) | 2026-02-11 | — | — | EP | disclosed |
| US-12540113-B2 | Method of producing carboxylic acid fluoride | KANTO DENKA KOGYO CO., LTD. (JP) | 2026-02-03 | — | — | US | disclosed |
| US-12325788-B2 | Plasticized PVC admixtures with surface modifying macromolecules and articles made therefrom | Evonik Canada Inc. (CA) | 2025-06-10 | — | — | US | disclosed |
| US-20250110101-A1 | PER AND POLYFLUOROALKYL SUBSTANCE MEASUREMENT | DEXSIL CORPORATION (US) | 2025-04-03 | — | — | US | disclosed |
| CN-118978747-A | Low-carbon high-barrier biodegradable mulch film and preparation method thereof | 丹阳恒绿新材料有限公司 | 2024-11-19 | — | — | CN | disclosed |
| WO-1997040129-A1 | N-ACYL ETHYLENEDIAMINETRIACETIC ACID SURFACTANTS AS ENZYME COMPATIBLE SURFACTANTS, STABILIZERS AND ACTIVATORS | HAMPSHIRE CHEMICAL CORP. (US) | 1997-10-30 | — | — | WO | disclosed |
| WO-1997040126-A1 | ULTRA MILD DETERGENT COMPOSITIONS | HAMPSHIRE CHEMICAL CORP. (US) | 1997-10-30 | — | — | WO | disclosed |
| US-5284972-A | N-acyl-N,N',N'-ethylenediaminetriacetic acid derivatives and process of preparing same | HAMPSHIRE CHEMICAL CORP. (US) | 1994-02-08 | — | — | US | disclosed |
| US-5162405-A | Single-functional and mixtures of multi-functional oligomeric performance additive compositions and their uses | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1992-11-10 | — | — | US | disclosed |
| US-5013777-A | Benzosulfonic acids as end groups of engineering thermoplastic resins; fireproofing; oxidation and UV resistances; photostabilizers | ATOCHEM NORTH AMERICA, INC. (US) | 1991-05-07 | — | — | US | disclosed |
| EP-0332761-A2 | Single-functional and mixtures of multifunctional oligomeric performance additive compositions, and their use | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1989-09-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649202-B2 | Fluorinated esters as lubricants for heat transfer fluids | F12, MUC1, F13A1 | THRB 3543/4885CA2 1038/4885LMNA 3139/4885 |
| US-12540113-B2 | Method of producing carboxylic acid fluoride | CA3, CA6, CA1 | THRB 578/4885CA2 5/4885LMNA 3105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.